| COVID-19, immune system response, hyperinflammation and repurposingantirheumatic drugs A Tufan, AA Güler, M Matucci-Cerinic Turkish journal of medical sciences 50 (9), 620-632, 2020 | 622 | 2020 |
| Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study N Atas, B Armagan, E Bodakci, H Satis, A Sari, NSY Bilge, RB Salman, ... Rheumatology international 40 (1), 41-48, 2020 | 57 | 2020 |
| Predictors of persistent inflammation in familial Mediterranean fever and association with damage H Babaoglu, B Armagan, E Bodakci, H Satis, N Atas, A Sari, ... Rheumatology 60 (1), 333-339, 2021 | 30 | 2021 |
| The assessment of serum ACE activity in COVID-19 and its association with clinical features and severity of the disease A Avanoglu Guler, N Tombul, P Aysert Yıldız, HS Özger, K Hızel, ... Scandinavian Journal of Clinical and Laboratory Investigation 81 (2), 160-165, 2021 | 26 | 2021 |
| Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review H Karadeniz, AA Güler, N Atas, H Satış, RB Salman, H Babaoglu, A Tufan Rheumatology International 40 (1), 169-173, 2020 | 20 | 2020 |
| Association of core muscle endurance times with balance, fatigue, physical activity level, and kyphosis angle in patients with ankylosing spondylitis DC Sarac, S Bayram, NG Tore, F Sari, AA Guler, A Tufan, D Oskay JCR: Journal of Clinical Rheumatology 28 (1), e135-e140, 2022 | 18 | 2022 |
| Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients N Atas, GA Eroglu, HN Sodan, BO Ozturk, H Babaoglu, H Satis, ... Clin Exp Rheumatol 39 (5), 30-36, 2021 | 16 | 2021 |
| Factors associated with damage in patients with familial Mediterranean fever H Babaoglu, B Armagan, E Bodakci, H Satis, N Atas, A Sari, NSY Bilge, ... Clin Exp Rheumatol 127 (5), 42-48, 2020 | 13 | 2020 |
| COVID-19 in chronic diseases A AVANOĞLU GÜLER, M ÖZTÜRK Gazi Medical Journal 31, 2020 | 13 | 2020 |
| The prognostic value of lung injury and fibrosis markers, KL-6, TGF-β1, FGF-2 in COVID-19 patients H Karadeniz, A Avanoğlu Güler, HS Özger, PA Yıldız, G Erbaş, G Bozdayı, ... Biomarker Insights 17, 11772719221135443, 2022 | 12 | 2022 |
| Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for the evaluation of patients with inflammation of unknown origin RB Salman, SG Ateş, H Satiş, A Tufan, ÜÖ Akdemir, D Yapar, N Ataş, ... JCR: Journal of Clinical Rheumatology 27 (6), 219-225, 2021 | 11 | 2021 |
| Parotid elastography: a potential alternative to replace labial biopsy in classification of patients with primary Sjögren’s syndrome? H Satış, E Cindil, RB Salman, D Yapar, NB Demir, E Temel, H Babaoğlu, ... Clinical rheumatology 39, 3707-3713, 2020 | 11 | 2020 |
| Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’s disease N Ataş, H Babaoğlu, E Demirel, B Çelik, RB Salman, H Satış, H Karadeniz, ... European Journal of Rheumatology 7 (3), 99, 2020 | 11 | 2020 |
| Diaphragmatic muscle thickness and diaphragmatic function are reduced in patients with systemic lupus erythematosus compared to those with primary Sjögren’s syndrome H Satış, E Cindil, RB Salman, D Yapar, E Temel, NB Demir, H Babaoğlu, ... Lupus 29 (7), 715-720, 2020 | 10 | 2020 |
| Comparison of miniaturized percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for the treatment of large kidney stones: a randomized prospective study … A Guler, A Erbin, B Ucpinar, M Savun, O Sarilar, MF Akbulut | 10 | 2019 |
| Venous inflammation might be one of the features of VEXAS syndrome and associated thrombosis H Karadeniz, M Cerit, A Avanoğlu Güler, A Tufan, Y Kanthi Rheumatology 62 (9), e269-e270, 2023 | 8 | 2023 |
| Lacrimal gland ultrasonography and elastography as a diagnostic and activity tool for primary Sjögren's syndrome H Karadeniz, M Cerit, AA Güler, RB Salman, H Satış, D Yıldırım, B Göker, ... International Journal of Rheumatic Diseases 26 (6), 1083-1090, 2023 | 7 | 2023 |
| Work productivity impairment in patients with familial Mediterranean fever and effects of interleukin-1 antagonists E Suticen, N Atas, AA Guler, O Akdogan, H Babaoğlu, H Satis, ... Clinical Rheumatology 40, 2865-2871, 2021 | 7 | 2021 |
| Frequency, characteristics, and clinical determinants of ‘prodrome’in familial Mediterranean fever patients H Babaoglu, N Atas, O Varan, H Satis, R Bilici Salman, A Guler, ... Scandinavian Journal of Rheumatology 49 (2), 154-158, 2020 | 7 | 2020 |
| Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis H Karadeniz, AA Güler, G Koca, RB Salman, H Satış, N Ataş, H Babaoğlu, ... Clinical Rheumatology, 1-8, 2022 | 6 | 2022 |
